The aetiology of type I diabetes

Bailliere's Best Practice and Research in Clinical Endocrinology and Metabolism

Volumn 13, Issue 2, 1999, Pages 181-195

  Chowdhury, Tahseen A ^a   Mijovic, Catherine H ^b   Barnett, Anthony H ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Cows' milk protein; Environmental factors; Human leukocyte antigen (HLA); Major histocompatibility complex (MHC); Susceptibility genes; Type I diabetes; Viruses

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; INSULIN; MILK PROTEIN;

DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC RISK; HEREDITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; REVIEW; RISK; TANDEM REPEAT; VIRUS INFECTION;

EID: 0033495395     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.1999.0015     Document Type: Article

References (87)

1. Bingley P J, Gale E AM. The incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6. British Medical Journal. 298:1989;558-560.
2. Leslie R DG, Atkinson M A, Notkins A L. Autoantigens IA-2 and GAD in Type 1 (insulin-dependent) diabetes. Diabetologia. 42:1999;3-14.
3. Lo S SS, Tun R YM, Hawa H, Leslie R DG. Studies of diabetic twins. Diabetes Metabolism Reviews. 7:1991;233-238.
4. Green A, Sjolie A K, Eshoj O. The epidemiology of diabetes mellitus. Pickup J C, Williams G. Textbook of diabetes. 1992;1-16.
5. Karvonen M, Tuomilehto J, Libman I, LaPorte R. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin dependent) diabetes mellitus. Diabetologia. 36:1993;883-892.
6. Muntoni S A, Fonte M T, Stoduto S. Incidence of insulin-dependent diabetes mellitus among Sardinian heritage children born in Lazio region, Italy. Lancet. 349:1997;160-162.
7. Pozzilli P, Signore A, Williams A J, Beales P E. NOD mouse colonies around the world - recent facts and figures. Immunology Today. 14:1993;193-196.
8. Bodansky H J, Staines A, Stephenson D. Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. British Medical Journal. 304:1992;1020-1022.
9. Leslie R DG, Elliot R B. Early environmental events as a cause of IDDM. Evidence and implications. Diabetes. 43:1994;843-850.
10. Rook G AW, Stanford J L. Give us this day our daily germs. Immunology Today. 19:1998;113-116.
11. Singal D P, Blajchman M A. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes. 22:1973;429-432.
12. Davies J L, Kawaguchi Y, Bennett S T. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 371:1994;130-136.
13. Bell G I, Horita S, Karam J H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 33:1984;176-183.
14. She J X, Marron M P. Genetic susceptibility factors in type 1 diabetes: linkage disequilibrium and functional analyses. Current Opinion in Immunology. 10:1998;682-689.
15. Schranz D B, Lermark A. Immunology in diabetes: an update. Diabetes Metabolism Reviews. 14:1998;3-29.
16. Risch N, Ghosh S, Todd J A. Statistical evaluation of multiple locus linkage data in experimental species and relevance to human studies: application to murine and human IDDM. American Journal of Human Genetics. 53:1993;702-714.
17. Mein C A, Esposito L, Dunn M G. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nature Genetics. 19:1998;297-300.
18. Spielman R S, McGinnis R E, Ewens W J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics. 52:1993;506-516.
19. Esposito L, Hill N J, Pritchard L E. Genetic analysis of chromosome 2 in Type 1 diabetes. Analysis of putative loci IDDM7, IDDM12 and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. Diabetes. 47:1998;1797-1799.
20. Concannon P, Gogolin-Ewens K J, Hinds D A. A second generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nature Genetics. 19:1998;292-296.
21. Lernmark A, Ott J. Sometimes it's hot, sometimes it's not. Nature Genetics. 19:1998;213-214.
22. McDuffie M. Genetics of autoimmune diabetes in animal models. Current Opinion in Immunology. 10:1998;704-709.
23. Todd J A, Aitman T J, Cornall R J. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature. 351:1991;542-547.
24. Campbell R D, Trowsdale J. Map of the human MHC. Immunology Today. 14:1993;349-352.
25. She J X. Susceptibility to Type 1 diabetes: HLA-DQ and DR revisited. Immunology Today. 17:1996;323-329.
26. Thorsby E. Invited Anniversary review: HLA associated diseases. Human Immunology. 53:1997;1-11.
27. Pugliese A, Giannani R, Moromisato R. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first degree relatives of patients with IDDM. Diabetes. 45:1995;608-613.
28. van der Awera B, van Waeyenberge C, Schuit F. DRB10403 protects against IDDM in Caucasians with the high-risk heterozygous DQA10301-DQB10302/DQA10501/DQB10201 genotype. Belgian Diabetes Registry. Diabetes. 44:1995;527-530.
29. Undlein D E, Friede T, Rammensee H G. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes. 46:1977;143-149.
30. Sanjeevi C B, Hook P, Landin-Olsson M. DR4 subtypes and their molecular properties in a population based study of Swedish childhood diabetes. Tissue Antigens. 47:1996;275-283.
31. Nejentsev S, Reijonen H, Adojaan B. The effect of HLA-B allele on the IDDM risk defined by the DRB1*04 subtypes and DQB1*0302. Diabetes. 45:1997;1888-1892.
32. Todd J A, Bell J I, McDevitt H O. HLA-DQB1 gene contributes to the genetic susceptibility to insulin dependent diabetes mellitus. Dupont B. Immunobiology of HLA. 1989;402-403 Springer-Verlag, New York.
33. Singer S M, Tisch R, Yang X D. Prevention of diabetes in NOD mice by a mutated I-Ab transgene. Diabetes. 47:1998;1570-1577.
34. Awata T, Kuzuya T, Matsuda A. High frequency of aspartic acid at position 57 of HLA-DQ B-chain in Japanese IDDM patients and nondiabetic subjects. Diabetes. 39:1990;266-269.
35. Khalil I, d'Auriol L, Gobet M. A combination of HLA-DQb Asp57-negative and HLA-DQa Arg52 confers susceptibility to insulin-dependent diabetes mellitus. Journal of Clinical Investigation. 85:1990;1315-1319.
36. Kawasaki E, Noble J, Erlich H. Transmission of DQ haplotypes to patients with type 1 diabetes. Diabetes. 47:1998;1970-1973.
37. Valdes A, McWeeney S, Thomson G. HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: application of the haplotype method. American Journal of Human Genetics. 60:1997;717-728.
38. Braun J H, Jardetsky T S, Garga J C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 364:1993;33-39.
39. Nepom G T, Kowk W W. Molecular basis for HLA-DQ associations with IDDM. Diabetes. 47:1998;1177-1184.
40. Hanifi-Moghaddam P, de Knijf P, Roep B. Genetic structure of IDDM1. Two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Diabetes. 47:1998;263-269.
41. Herberg J A, Beck S, Trowsdale J. TAPASIN, DAXX, RGL2, HKE2, and four new genes (BING1,3 to 5) form a dense cluster at the centromeric end of the MHC. Journal of Molecular Biology. 277:1998;839-857.
42. Mauricio D, Mandrup-Poulsen T. Apoptosis and the pathogenesis of IDDM. A question of life and death. Diabetes. 47:1998;1537-1543.
43. Cucca F, Congia M, Trowsdale J, Powis S H. Insulin-dependent diabetes mellitus and the major histocompatibility transporters TAP1 and TAP2: no association in a population with a high disease incidence. Tissue Antigens. 44:1994;234-240.
44. Undlein D, Akselen H E, Joner G. No independent associations of LMP2 and LMP7 polymorphism with susceptibility to develop IDDM. Diabetes. 46:1997;307-312.
45. Erlich H A, Rotter J I, Chang J D. Association of HLA-DPB1*0301 with insulin dependent diabetes mellitus in Mexican-Americans. Diabetes. 45:1996;610-614.
46. Noble J A, Valdes A M, Cook M. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian multiplex families. American Journal of Human Genetics. 59:1996;1134-1148.
47. Lie B, Akselsen H E, Joner G. HLA-associations in insulin-dependent diabetes mellitus: no independent association to particular DP genes. Human Immunology. 55:1997;170-175.
48. Cucca F, Goy J V, Kawaguchi Y. A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nature Genetics. 19:1998;301-303.
49. Bennett S T, Lucassen A M, Gough S C. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genetics. 9:1995;284-292.
50. Bennett S T, Wilson A J, Esposito L. Insulin VNTR allele-specific effect in Type 1 diabetes depends on identity of untransmitted paternal allele. Nature Genetics. 17:1997;350-352.
51. Pugliese A, Zeller M, Fernandez J A. The insulin gene transcribed in the human pancreas and the transcription level correlate with allelic variation at the INS-VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genetics. 15:1997;293-297.
52. Paquette J, Giannoukakis N, Polychronakos C. The INS 5′ variable number of tandem repeats is associated with IGF2 expression in humans. Journal of Biological Chemistry. 273:1998;14158-14164.
53. Vafiadis P, Bennett S T, Todd J A. Divergence between genetic determinants of IGF2 transcription levels in leukocytes and of IDDM2-encoded susceptibility to type 1 diabetes. Journal of Clinical Endocrinology and Metabolism. 83:1998;2933-2939.
54. Dahlquist G, Bennich S S, Kallen B. Intrauterine growth pattern and risk of childhood onset insulin dependent (type 1) diabetes: population based case-control study. British Medical Journal. 313:1996;1174-1177.
55. Luo D F, Buzzetti R, Rotter J I. Confirmation of three susceptibility genes to insulin dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8. Human Molecular Genetics. 5:1996;693-698.
56. Kim P KM, Dutra A S, Chandrasekharappa S C, Puck J M. Genomic structure and mapping of human FADD, an intracellular mediator of lymphocyte apoptosis. Journal of Immunology. 157:1996;5461-5466.
57. Iwata I, Nagafuchi S, Nakashima H. Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes. 48:1999;416-419.
58. Owerbach D, Naya F J. Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on chromosome 2q31-35. Diabetes. 46:1997;1069-1074.
59. Donner H, Rau H, Walfish P G. CTLA4 alanine 17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism. 82:1997;143-146.
60. Becker K G, Simon R, Bailey-Wilson J E. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune disease. Proceedings of the National Academy of Sciences of the USA. 95:1998;9979-9984.
61. Kristiansen O P, Zamani N, Johannesen C. Linkage and association between a CD4 gene polymorphism and IDDM in Danish IDDM patients. Diabetes. 47:1998;281-283.
62. Haverkos H W. Could the aetiology of IDDM be multifactorial? Diabetologia. 40:1997;1235-1240.
63. Roll U, Christe M R, Fuchtenbusch M. Perinatal autoimmunity in offspring of diabetic parents. The German multicenter BABY-DIAB study: detection of humoral responses to islet antigens in early childhood. Diabetes. 45:1996;967-973.
64. Diabetologia. 41:1998;1115-1156.
65. McIntosh E DG, Menser M A. A fifty year follow up of congenital rubella. Lancet. 340:1993;414-415.
66. Dahlquist C G, Frisk G, Ivarsson S. Indications that maternal Coxsackie B virus infection during pregnancy is a risk factor for childhood onset IDDM. Diabetologia. 38:1995;1371-1373.
67. Virtanen S M, Rasanen L, Ylonen M. Early introduction of dairy products associated with increased risk of IDDM in Finnish children. Diabetes. 42:1993;1786-1790.
68. Jenista J A, Powell K R, Menegus M A. Epidemiology of neonatal virus infection. Journal of Paediatrics. 104:1984;685-690.
69. Lonnrot M, Knip M, Roivainen M. Onset of Type 1 diabetes mellitus in infancy after enterovirus infections. Diabetic Medicine. 15:1997;431-434.
70. Dosch H M. The possible link between insulin dependent diabetes and dietary cows milk. Clinical Biochemistry. 26:1997;307-308.
71. Akerblom H, Knip M. Putative environmental factors in type 1 diabetes. Diabetes Metabolism Reviews. 41:1998;31-67.
72. Ellis T M, Ottendorfer E, Jodoin E. Cellular immune response to b casein: elevated but not specific for individuals with type 1 diabetes mellitus. Diabetologia. 41:1998;731-735.
73. Saukkonen T, Virtanene S M, Karppinen M. Significance of cow's milk protein antibodies as a risk factor for childhood IDDM: interactions with dietary cow's milk intake and HLA-DQB1 genotype. Diabetologia. 41:1998;72-78.
74. Singh B, Prange S, Jevnikar A M. Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus. Seminars in Immunology. 10:1998;79-86.
75. Herrath M G, Holz A, Homann D, Oldstone M A. Role of viruses in type 1 diabetes. Seminars in Immunology. 10:1998;87-100.
76. Conrad B, Weldmann E, Trucco G. A human endogenous retroviral superantigen as candidate autoimmune gene in type 1 diabetes. Cell. 90:1997;303-313.
77. Kawamura T, Nagata M, Utsugi T M, Yoon J W. Prevention of autoimmune type 1 diabetes by CD4+ suppressor cells in superantigen-treated non-obese diabetic mice. Journal of Immunology. 151:1997;4362-4370.
78. Badenhoop K, Donner H, Neumann J. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes. 48:1999;215-218.
79. Champsaur H F, Bottazzo G F, Bertrams J. Virologic, immunologic and genetic factors in insulin-dependent diabetes. Journal of Paediatrics. 100:1982;15-20.
80. 65is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia. 41:1998;40-46.
81. Parkkonnen P, Hyoty H, Ilonen J. Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 β chain. Clinical and Experimental Immunology. 95:1990;287-293.
82. Gamble D R. Relation of antecedent illness to development of diabetes in children. British Medical Journal. 2:1980;99-101.
83. Helmke K, Otten A, Willems W. Islet cell antibodies in children with mumps infection. Lancet. 2:1980;211-212.
84. Pak C Y, Cha C Y, Rajotte R V. Human pancreatic islet cell-specific 38 kDa autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologia. 33:1990;569-572.
85. Ginsberg-Fellner F, Witt M E, Yagihashi S. Congenital rubella syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia. 27:1984;87-89.
86. Karounos D G, Wolinsky J S, Thomas J W. Monoclonal antibody to rubella virus capid protein recognises a beta-cell antigen. Journal of Immunology. 150:1993;3080-3085.
87. Hao W, Serreze D V, McCullough D K. Insulin (auto) antibodies from human IDDM cross react with retroviral antigen p73. Journal of Autoimmunity. 6:1993;787-798.